Surgery Grand Rounds
June 11, 2014
Duke North – Room 2002
Surgical Grand Rounds
7:00 – 7:30 a.m.
“The role of Toll-like receptor 4 in lung ischemia-reperfusion injury”
Giorgio Zanotti, M.D.
Chief Resident, General Surgery
Moderator: Robert Davis, M.D.
7:30 – 8:00 a.m.
“Advancing Extracorporeal Life Support Therapies”
John Haney, M.D.
Chief Resident, Cardiothoracic Surgery
Moderator: Mani Daneshmand, M.D.
8:00 a.m. – 8:30 a.m.
“Abdominal Wall Reconstruction:
The Essentials of Ventral Hernia Repair”
David Lo, M.D.
Senior Assistant Resident II, General Surgery
Moderator: Alexander Perez, M.D.
Surgical Case Conference
8:30 – 9:00 a.m.
Moderator: Debra Sudan, M.D.
Presenter Disclosure of Financial Relationships: Drs. D. Sudan, Perez, Zanotti, Haney, Daneshmand, and Lo indicate no financial relationships relative to the content presented and no personal/financial relationships to disclose which are relative to this activity. Dr. Davis indicates he is a Principal Investigator for Vitrolife; a Consultant for Allmed, Transplant Analytics, and Transplant Management Group; and an Advisory Board Member for Bayer Pharmaceuticals, but has no personal/financial relationships to disclose which are relative to this activity.
RSS Activity Medical Director(s) Disclosure: Dr. Ranjan Sudan has no personal/financial relationships to disclose which are relative to this activity.
---Global Learning Objectives---
- Review and discuss new advances in general surgery;
- Present and discuss case studies, protocols, treatment guidelines and surgical/pathology report appropriate to General Surgery practice;
- Review and discuss clinical research findings and other evidence from pertinent literature.
The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
---Unapproved Use Disclosure---
Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (Not FDA approved) ; and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and /or unsupported opinion. Faculty at this event may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education, and is not intended to promote off-label use of these medications. If you have any questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
The Duke University School Of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in this activity.
In order to receive CME Credit, learners must sign in at the beginning of this event.